Groove Biopharma

BiotechnologySeries BSeattle, USgroovebiopharma.com

Latest round

Series B

Last raised

Dec 2011

Total raised

$16M

Investors

7

About Groove Biopharma

Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity.

Who invested in Groove Biopharma

7 investors across 3 rounds

See all investors in Groove Biopharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 12, 2011

    Amount

    $8.4M

    Investors

    Locked

  2. Series A

    Apr 26, 2010

    Amount

    $3.9M

    Investors

    Locked

  3. Series A

    Aug 15, 2008

    Amount

    $3.5M

    Investors

    Locked

Questions about Groove Biopharma

Who invested in Groove Biopharma?

Groove Biopharma has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Groove Biopharma raised?

Groove Biopharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Groove Biopharma last raise money?

Groove Biopharma's most recent round on record is a Series B, in Dec 2011.

What does Groove Biopharma do?

Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity.

Where is Groove Biopharma headquartered?

Groove Biopharma is headquartered in Seattle, US.

Which VCs invest in companies like Groove Biopharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Groove Biopharma's stage. Their profiles are linked below.

Raising like Groove Biopharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.